It is an observation that in delivering therapeutic drugs, incorrect doses of drugs are sometimes administered.

Given the critical nature of the illnesses for which cytarabine is given, an interprofessional, coordinated team approach to therapy and monitoring is absolutely essential. This team includes specialists, mid-level practitioners, family clinicians, oncology specialty-trained nurses, and pharmacists, preferably with oncology specialization. By working collaboratively and engaging in open information-sharing regarding the latest information on the patient's case, patient outcomes can be optimized, and adverse events minimized when utilizing cytarabine therapy. [Level 5]